Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Variable response of uterine leiomyomas after GnRH agonist therapy.

Literature DB >> 9389836

Variable response of uterine leiomyomas after GnRH agonist therapy.

I A Brosens.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 1997 PMID： 9389836 DOI： 10.1016/s0015-0282(97)90366-6

Source DB: PubMed Journal: Fertil Steril ISSN： 0015-0282 Impact factor: 7.329

Keyword Cloud
Cited

× No keyword cloud information.

2 in total

1. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T₂ weighted MR imaging.

Authors: Shenghua Yang; Fanjing Kong; Ruijie Hou; Fengmei Rong; Nana Ma; Shaoping Li; Jun Yang
Journal: Br J Radiol Date: 2017-03-03 Impact factor: 3.039

Review 2. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids.

Authors: Nicoletta Biglia; Silvestro Carinelli; Antonio Maiorana; Marta D'Alonzo; Giuseppe Lo Monte; Roberto Marci
Journal: Drug Des Devel Ther Date: 2014-02-20 Impact factor: 4.162

2 in total

Variable response of uterine leiomyomas after GnRH agonist therapy.

1. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T2 weighted MR imaging.

Review 2. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids.

1. Ultrasound guided high-intensity focused ultrasound combined with gonadotropin releasing hormone analogue (GnRHa) ablating uterine leiomyoma with homogeneous hyperintensity on T₂ weighted MR imaging.